Nature 535, 511–516 (2016); doi:10.1038/nature18634

In the interests of transparency, in this Article we wish to amend the competing financial interests statement to read: “Tuebingen University has filed a provisional patent application that covers the compound lugdunin and derivatives thereof, as well as the application of lugdunin-producing bacteria for the prevention of bacterial infections (European patent application number EP 15 160 285.1).” The online versions of the paper have been corrected.